Robin Spiller
Robin Spiller
University of Nottingham, Nottingham Digestive Diseases Centre
Verified email at
Cited by
Cited by
Functional bowel disorders
GF Longstreth, WG Thompson, WD Chey, LA Houghton, F Mearin, ...
Gastroenterology 130 (5), 1480-1491, 2006
Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acuteCampylobacter enteritis and in post-dysenteric irritable bowel syndrome
RC Spiller, D Jenkins, JP Thornley, JM Hebden, T Wright, M Skinner, ...
Gut 47 (6), 804-811, 2000
Bowel disorders
BE Lacy, F Mearin, L Chang, WD Chey, AJ Lembo, M Simren, R Spiller
Gastroenterology 150 (6), 1393-1407. e5, 2016
Guidelines on the irritable bowel syndrome: mechanisms and practical management
R Spiller, Q Aziz, F Creed, A Emmanuel, L Houghton, P Hungin, R Jones, ...
Gut 56 (12), 1770-1798, 2007
Rome III The functional gastrointestinal disorders
A Drossman
Gastroenterology 130, 1377-1556, 2006
Intestinal microbiota in functional bowel disorders: a Rome foundation report
M Simrén, G Barbara, HJ Flint, BMR Spiegel, RC Spiller, S Vanner, ...
Gut 62 (1), 159-176, 2013
Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients
KR Neal, J Hebden, R Spiller
Bmj 314 (7083), 779, 1997
Postinfectious irritable bowel syndrome
R Spiller, K Garsed
Gastroenterology 136 (6), 1979-1988, 2009
Bowel disorders.
F Mearin, BE Lacy, L Chang, WD Chey, AJ Lembo, M Simren, R Spiller
Gastroenterology, 2016
Eradication of Helicobacter pylori using one‐week triple therapies combining omeprazole with two antimicrobials: the MACH I Study
T Lind, SV van Zanten, P Unge, R Spiller, E Bayerdörffer, C O'Morain, ...
Helicobacter 1 (3), 138-144, 1996
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS
SP Dunlop, D Jenkins, KR Neal, RC Spiller
Gastroenterology 125 (6), 1651-1659, 2003
The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
T Lind, F Mégraud, P Unge, E Bayerdörffer, C O'Morain, R Spiller, ...
Gastroenterology 116 (2), 248-253, 1999
The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man.
RC Spiller, IF Trotman, BE Higgins, MA Ghatei, GK Grimble, YC Lee, ...
Gut 25 (4), 365-374, 1984
Effect of meal viscosity and nutrients on satiety, intragastric dilution, and emptying assessed by MRI
L Marciani, PA Gowland, RC Spiller, P Manoj, RJ Moore, P Young, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 280 (6 …, 2001
Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes
SP Dunlop, J Hebden, E Campbell, J Naesdal, L Olbe, AC Perkins, ...
American Journal of Gastroenterology 101 (6), 1288-1294, 2006
Postinfectious irritable bowel syndrome
RC Spiller
Gastroenterology 124 (6), 1662-1671, 2003
Intestinal barrier function in health and gastrointestinal disease
M Camilleri, K Madsen, R Spiller, BG Van Meerveld, GN Verne
Neurogastroenterology & Motility 24 (6), 503-512, 2012
Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome
SP Dunlop, D Jenkins, RC Spiller
The American journal of gastroenterology 98 (7), 1578-1583, 2003
Irritable bowel syndrome: a little understood organic bowel disease?
NJ Talley, R Spiller
The Lancet 360 (9332), 555-564, 2002
Mechanisms of hypersensitivity in IBS and functional disorders
F Azpiroz, M Bouin, M Camilleri, EA Mayer, P Poitras, J Serra, RC Spiller
Neurogastroenterology & Motility 19, 62-88, 2007
The system can't perform the operation now. Try again later.
Articles 1–20